Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia.

Sheshadri A, Godoy M, Erasmus JJ, Gruschkus S, Hasan A, Evans SE, Barreda-Garcia J, Chemaly RF, Dickey B, Ost D.

BMJ Open Respir Res. 2019 Dec 23;6(1):e000471. doi: 10.1136/bmjresp-2019-000471. eCollection 2019. Erratum in: BMJ Open Respir Res. 2020 Jan;7(1):.

2.

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract.

Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS.

Clin Infect Dis. 2019 Dec 3. pii: ciz1167. doi: 10.1093/cid/ciz1167. [Epub ahead of print]

PMID:
31915807
3.

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation.

Marty FM, Ljungman PT, Chemaly RF, Wan H, Teal VL, Butterton JR, Yeh WW, Leavitt RY, Badshah CS.

Am J Transplant. 2019 Dec 28. doi: 10.1111/ajt.15764. [Epub ahead of print]

PMID:
31883426
4.

A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients.

Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M.

Clin Infect Dis. 2019 Dec 3. pii: ciz1166. doi: 10.1093/cid/ciz1166. [Epub ahead of print]

PMID:
31793991
5.

Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.

Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP.

Open Forum Infect Dis. 2019 Nov 25;6(11):ofz458. doi: 10.1093/ofid/ofz458. eCollection 2019 Nov.

6.

Antigenic fingerprinting of RSV-A infected hematopoietic cell transplant recipients reveals importance of mucosal anti-RSV-G antibodies in control of RSV infection in humans.

Fuentes S, Hahn M, Chilcote K, Chemaly RF, Shah DP, Ye X, Avadhanula V, Piedra PA, Golding H, Khurana S.

J Infect Dis. 2019 Nov 20. pii: jiz608. doi: 10.1093/infdis/jiz608. [Epub ahead of print]

PMID:
31745552
7.

Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014.

Kmeid J, Kulkarni PA, Batista MV, El Chaer F, Prayag A, Ariza-Heredia EJ, Mulanovich VE, Chemaly RF.

BMC Infect Dis. 2019 Nov 6;19(1):934. doi: 10.1186/s12879-019-4586-y.

8.

Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management.

Khawaja F, Batista MV, El Haddad L, Chemaly RF.

Curr Opin Infect Dis. 2019 Dec;32(6):565-574. doi: 10.1097/QCO.0000000000000607.

PMID:
31567572
9.

Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.

El Haddad L, Ghantoji SS, Park AK, Batista MV, Schelfhout J, Hachem J, Lobo Y, Jiang Y, Rondon G, Champlin R, Chemaly RF.

J Med Virol. 2020 Jan;92(1):86-95. doi: 10.1002/jmv.25574. Epub 2019 Sep 3.

PMID:
31448830
10.

Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.

Pergam SA, Englund JA, Kamboj M, Gans HA, Young JH, Hill JA, Savani B, Chemaly RF, Dadwal SS, Storek J, Duchin J, Carpenter PA.

Biol Blood Marrow Transplant. 2019 Nov;25(11):e321-e330. doi: 10.1016/j.bbmt.2019.07.034. Epub 2019 Aug 5. Review.

PMID:
31394271
11.

Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates.

Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA.

Jt Comm J Qual Patient Saf. 2019 Oct;45(10):686-693. doi: 10.1016/j.jcjq.2019.06.001. Epub 2019 Jul 29.

PMID:
31371099
12.

Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.

Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP.

Open Forum Infect Dis. 2019 Jul 19;6(7):ofz247. doi: 10.1093/ofid/ofz247. eCollection 2019 Jul. Erratum in: Open Forum Infect Dis. 2019 Nov 25;6(11):ofz458.

13.

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Khawaja F, Chemaly RF.

Haematologica. 2019 Jul;104(7):1322-1331. doi: 10.3324/haematol.2018.215152. Epub 2019 Jun 20. Review.

14.

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation.

Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C.

Clin Infect Dis. 2019 Jun 8. pii: ciz490. doi: 10.1093/cid/ciz490. [Epub ahead of print]

PMID:
31179485
15.

Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.

Sheshadri A, Karimipour M, Vakil E, Bashoura L, Godoy M, Arain MH, Evans SE, Dickey BF, Ost DE, Chemaly RF, Faiz SA.

Transpl Infect Dis. 2019 Aug;21(4):e13105. doi: 10.1111/tid.13105. Epub 2019 May 28.

PMID:
31081570
16.

Reply to Jain et al.

Foolad F, Chemaly RF.

Clin Infect Dis. 2019 Nov 27;69(12):2235-2236. doi: 10.1093/cid/ciz379. No abstract available.

PMID:
31074774
17.

Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study.

Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC.

Open Forum Infect Dis. 2019 Apr 4;6(5):ofz173. doi: 10.1093/ofid/ofz173. eCollection 2019 May.

18.

Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey.

Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF.

Open Forum Infect Dis. 2019 Apr 2;6(4):ofz138. doi: 10.1093/ofid/ofz138. eCollection 2019 Apr.

19.

Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.

Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA.

Front Immunol. 2019 Mar 29;10:706. doi: 10.3389/fimmu.2019.00706. eCollection 2019.

20.

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A, Alousi A, Afrough A, Oran B, Ciurea S, Kebriaei P, Popat UR, Qazilbash MH, Shpall EJ, Champlin RE, Bashir Q.

Curr Res Transl Med. 2019 May;67(2):51-55. doi: 10.1016/j.retram.2019.01.001. Epub 2019 Jan 23.

PMID:
30683577
21.

In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.

Chemaly RF, Hill JA, Voigt S, Peggs KS.

Antiviral Res. 2019 Mar;163:50-58. doi: 10.1016/j.antiviral.2019.01.008. Epub 2019 Jan 21. Review.

22.

Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.

Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP.

Biol Blood Marrow Transplant. 2019 Apr;25(4):800-809. doi: 10.1016/j.bbmt.2018.11.022. Epub 2018 Dec 3.

PMID:
30521974
23.

Reply to Giménez et al.

El Haddad L, Ariza-Heredia E, Chemaly RF.

J Infect Dis. 2019 Apr 16;219(9):1512-1513. doi: 10.1093/infdis/jiy687. No abstract available.

PMID:
30496440
24.

A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.

El Haddad L, Harb CP, Gebara MA, Stibich MA, Chemaly RF.

Clin Infect Dis. 2019 Jun 18;69(1):167-178. doi: 10.1093/cid/ciy947.

PMID:
30395179
25.

Viral therapeutics: where we are and where we are going.

Chemaly RF, Clark TW.

Curr Opin Infect Dis. 2018 Dec;31(6):512-513. doi: 10.1097/QCO.0000000000000507. No abstract available.

PMID:
30325760
26.

Paramyxovirus infections in hematopoietic cell transplant recipients.

Batista MV, El Haddad L, Chemaly RF.

Curr Opin Infect Dis. 2018 Dec;31(6):542-552. doi: 10.1097/QCO.0000000000000503. Review.

PMID:
30320640
27.

The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.

El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF.

J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592.

PMID:
30295846
28.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ; SUPPRESS Trial Clinical Study Group.

Biol Blood Marrow Transplant. 2019 Feb;25(2):369-381. doi: 10.1016/j.bbmt.2018.09.038. Epub 2018 Oct 4.

29.

Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.

Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF.

Clin Infect Dis. 2019 May 2;68(10):1641-1649. doi: 10.1093/cid/ciy760.

PMID:
30202920
30.

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.

Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF.

Transpl Infect Dis. 2018 Dec;20(6):e12994. doi: 10.1111/tid.12994. Epub 2018 Sep 21.

31.

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2019 Apr 8;68(8):1420-1426. doi: 10.1093/cid/ciy696.

PMID:
30137245
32.

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.

Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF.

J Antimicrob Chemother. 2018 Nov 1;73(11):3162-3169. doi: 10.1093/jac/dky311.

PMID:
30113677
33.

Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.

Foolad F, Aitken SL, Chemaly RF.

Expert Rev Clin Pharmacol. 2018 Oct;11(10):931-941. doi: 10.1080/17512433.2018.1500897. Epub 2018 Sep 18. Review.

PMID:
30004790
34.

Update on infection control practices in cancer hospitals.

Ariza-Heredia EJ, Chemaly RF.

CA Cancer J Clin. 2018 Sep;68(5):340-355. doi: 10.3322/caac.21462. Epub 2018 Jul 9. Review.

35.

Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections.

Sheshadri A, Shah DP, Godoy M, Erasmus JJ, Song J, Li L, Evans SE, Chemaly RF, Dickey BF, Ost DE.

PLoS One. 2018 May 17;13(5):e0197418. doi: 10.1371/journal.pone.0197418. eCollection 2018.

36.

Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE.

Transpl Int. 2018 Jun;31(6):639-648. doi: 10.1111/tri.13142. Epub 2018 Mar 13.

37.

Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.

Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA.

J Infect Dis. 2018 Mar 28;217(8):1247-1256. doi: 10.1093/infdis/jiy026.

PMID:
29365155
38.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

39.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA.

Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.

40.

Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms.

El Haddad L, Ghantoji SS, Stibich M, Fleming JB, Segal C, Ware KM, Chemaly RF.

BMC Infect Dis. 2017 Oct 10;17(1):672. doi: 10.1186/s12879-017-2792-z.

41.

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, Chemaly RF, Champlin RE, Gulbis A, Ciurea SO.

Biol Blood Marrow Transplant. 2018 Feb;24(2):353-358. doi: 10.1016/j.bbmt.2017.09.018. Epub 2017 Oct 3.

42.

Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers.

Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF.

J Med Virol. 2018 Jan;90(1):50-60. doi: 10.1002/jmv.24930. Epub 2017 Sep 14.

43.

A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL.

Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M.

Contemp Clin Trials Commun. 2016 Dec 15;4:84-89. doi: 10.1016/j.conctc.2016.05.002. Epub 2016 May 5.

44.

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.

El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF.

Cancer. 2017 Jun 15;123(12):2329-2337. doi: 10.1002/cncr.30599. Epub 2017 Feb 8.

45.

Antiviral therapy for respiratory viral infections in immunocompromised patients.

Shahani L, Ariza-Heredia EJ, Chemaly RF.

Expert Rev Anti Infect Ther. 2017 Apr;15(4):401-415. doi: 10.1080/14787210.2017.1279970. Epub 2017 Jan 16. Review.

PMID:
28067078
46.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK.

Biol Blood Marrow Transplant. 2017 Mar;23(3):512-521. doi: 10.1016/j.bbmt.2016.12.621. Epub 2017 Jan 5.

47.

The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study.

Liu X, Bian S, Zhang Y, Zhang L, Yang Q, Wang P, Xu Y, Shi X, Zhang Y, Chemaly RF.

BMC Infect Dis. 2016 Dec 12;16(1):750.

48.

Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.

Nesher L, Tarrand J, Chemaly RF, Rolston KV.

Support Care Cancer. 2017 Apr;25(4):1063-1069. doi: 10.1007/s00520-016-3493-7. Epub 2016 Nov 24.

49.

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.

Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12632. Epub 2016 Dec 28.

PMID:
27862740
50.

Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.

El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF.

Antiviral Res. 2016 Nov;135:91-96. doi: 10.1016/j.antiviral.2016.08.027. Epub 2016 Sep 1.

PMID:
27594527

Supplemental Content

Loading ...
Support Center